<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Spatuzza C</submitter><funding>Telethon</funding><pagination>4402-16</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC2490745</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>36(13)</volume><pubmed_abstract>Bruton's tyrosine kinase (Btk) is required for B-cell development. Btk deficiency causes X-linked agammaglobulinemia (XLA) in humans and X-linked immunodeficiency (Xid) in mice. Btk lacks a negative regulatory domain and may rely on cytoplasmic proteins to regulate its activity. Consistently, we identified an inhibitor of Btk, IBtk, which binds to the PH domain of Btk and down-regulates the Btk kinase activity. IBtk is an evolutionary conserved protein encoded by a single genomic sequence at 6q14.1 cytogenetic location, a region of recurrent chromosomal aberrations in lymphoproliferative disorders; however, the physical and functional organization of IBTK is unknown. Here, we report that the human IBTK locus includes three distinct mRNAs arising from complete intron splicing, an additional</pubmed_abstract><journal>Nucleic acids research</journal><pubmed_title>Physical and functional characterization of the genetic locus of IBtk, an inhibitor of Bruton's tyrosine kinase: evidence for three protein isoforms of IBtk.</pubmed_title><pmcid>PMC2490745</pmcid><funding_grant_id>TGM06S01</funding_grant_id><pubmed_authors>Spatuzza C</pubmed_authors><pubmed_authors>Quinto I</pubmed_authors><pubmed_authors>Di Salle E</pubmed_authors><pubmed_authors>Janda E</pubmed_authors><pubmed_authors>Fierro O</pubmed_authors><pubmed_authors>Capparelli R</pubmed_authors><pubmed_authors>Faraonio R</pubmed_authors><pubmed_authors>Schiavone M</pubmed_authors><pubmed_authors>Scala G</pubmed_authors><pubmed_authors>Argiriou N</pubmed_authors><pubmed_authors>Sardiello M</pubmed_authors><pubmed_authors>Fiume G</pubmed_authors><pubmed_authors>Simonetta M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Physical and functional characterization of the genetic locus of IBtk, an inhibitor of Bruton's tyrosine kinase: evidence for three protein isoforms of IBtk.</name><description>Bruton's tyrosine kinase (Btk) is required for B-cell development. Btk deficiency causes X-linked agammaglobulinemia (XLA) in humans and X-linked immunodeficiency (Xid) in mice. Btk lacks a negative regulatory domain and may rely on cytoplasmic proteins to regulate its activity. Consistently, we identified an inhibitor of Btk, IBtk, which binds to the PH domain of Btk and down-regulates the Btk kinase activity. IBtk is an evolutionary conserved protein encoded by a single genomic sequence at 6q14.1 cytogenetic location, a region of recurrent chromosomal aberrations in lymphoproliferative disorders; however, the physical and functional organization of IBTK is unknown. Here, we report that the human IBTK locus includes three distinct mRNAs arising from complete intron splicing, an additional</description><dates><release>2008-01-01T00:00:00Z</release><publication>2008 Aug</publication><modification>2026-05-02T06:21:02.614Z</modification><creation>2019-03-27T00:16:00Z</creation></dates><accession>S-EPMC2490745</accession><cross_references><pubmed>18596081</pubmed><doi>10.1093/nar/gkn413</doi></cross_references></HashMap>